Evidence map›Paper›PMID 39941869›Full record

ArticleCancers2025

Serosal Patching with Glubran

Ahmad Mahamid, Eden Gerszman, Esther Kazlow, Aasem Abu Shtaya, Natalia Goldberg, Dvir Froylich, Riad Haddad

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmad MahamidDivion of Surgery, Carmel Medical Center, Haifa 3436212, Israel.ORCID 0000-0003-0007-5902
Eden GerszmanDivion of Surgery, Carmel Medical Center, Haifa 3436212, Israel.
Esther KazlowDivion of Surgery, Carmel Medical Center, Haifa 3436212, Israel.
Aasem Abu ShtayaThe Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3525433, Israel.ORCID 0000-0002-6873-3193
Natalia GoldbergThe Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3525433, Israel.
Dvir FroylichDivion of Surgery, Carmel Medical Center, Haifa 3436212, Israel.
Riad HaddadDivion of Surgery, Carmel Medical Center, Haifa 3436212, Israel.ORCID 0000-0003-3138-5495

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPostoperative pancreatic fistulae (POPFs) are a significant cause of morbidity following left pancreatectomy. We hypothesized that incorporating serosal patching with the application of a synthetic sealant, a modified cyanoacrylate (Glubran

methodsThis is a retrospective study of consecutive patients who underwent robot-assisted left pancreatectomy. The primary outcome was clinically significant POPFs within 90 days of surgery. Secondary outcomes included the incidence rate of POPFs (all the grades), 90-day morbidity, and 90-day mortality.

resultsWe compared outcomes between Glubran

conclusionsIncorporating serosal patching along with Glubran

Indexed as

Glubran®2pancreatectomypostoperative complicationspostoperative pancreatic fistularobot-assisted left pancreatectomysealantserosal patching

Identifiers

PMID39941869
PMCPMC11816142

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.